About SPR
At SPR, we are driven by a commitment and passion to improve the lives of millions of people living with pain. Many of us have experienced or seen the lasting impact of pain, and we feel privileged to offer a solution that has helped thousands reclaim their lives. By continuing to pioneer innovative treatments, we aim to offer hope and relief to those who suffer from pain.
![Amputee images](/sites/default/files/2024-11/iStock-817246896_amputee.jpg)
We Are SPR™
SPR is an innovative medical device company focused on non-opioid, non-surgical, minimally invasive pain management solutions. Our purpose is clear: to offer proprietary technologies that are used early in the treatment continuum to improve the lives of millions living with acute and chronic pain. We are dedicated to developing and delivering safe, effective treatments that provide meaningful patient outcomes, because we believe patients deserve the opportunity to get back to life — and we’re here to make that happen.
![Sprint Device](/sites/default/files/2024-11/SPRINT%20Device%20Image_4clr.png)
Our commitment to innovation
Our dedication to patients and pioneering innovative solutions comes to life through our groundbreaking SPR SPRINT® Peripheral Nerve Stimulation (PNS) System — a minimally invasive treatment engineered specifically for the peripheral nervous system. Supported by the largest body of clinical evidence in PNS, multi-million-dollar grants and contracts awarded by the Department of Defense and National Institutes of Health, and countless patient stories demonstrating life-changing relief, the SPRINT PNS System is designed to empower people to reclaim their lives from pain.
![SPR Leadership](/sites/default/files/2025-01/LeadershipNov2024ASMMtg.jpeg)
Leading with purpose
Our leadership team combines decades of experience in developing and commercializing groundbreaking neurostimulation therapies. With globally recognized leaders in interventional pain management, rehabilitation medicine, orthopedics, and biomedical engineering as our clinical and scientific advisors, we partner with the best in the field to revolutionize pain therapies and improve the lives of even more patients.
“Innovation is at the core of SPR, but it’s innovation with purpose — driven by the real-life stories of people living with pain. Our mission to deliver life-changing results, inspires every team member we hire, every investment we make, and every breakthrough we pursue.”
– Maria Bennett, President, CEO, and Founder of SPR
Milestones in innovation
The beginning of a vision
SPR was founded with a clear purpose: to revolutionize pain management. During this period, we secured foundational patents, designed and developed our first-generation SPRINT PNS System, demonstrated safety and efficacy in key pain areas, and laid the groundwork for what would become a trailblazing company in neurostimulation.
Breaking ground with FDA clearance
In 2016, we achieved FDA 510(k) clearance for the first-generation SPRINT PNS System, offering a minimally invasive solution for both acute and chronic pain in the back and/or extremities. This pivotal moment marked the start of our commercial journey.
Building a new market in pain management
The development and clearance of our next-generation single and dual lead SPRINT PNS System propelled us forward, as we embarked on building a new market in peripheral pain with increasing momentum. By 2019, we reached a key milestone—treating our 1,000th patient, validating the unmet need for a non-surgical, non-opioid pain management solution.
Increased commercial awareness and adoption
With continued clinical success and an expanded indication allowing for on-label treatment of headache and neck pain, our SPRINT PNS System reached over 5,000 patients by 2021, a testament to its growing impact. To respond to the commercial demand and support our US commercial expansion, SPR closed an oversubscribed growth equity financing.
Commercial demand and rapid growth
Our commitment to patient outcomes drove us to publish real-world evidence showing pain relief in over 70% of more than 6,100 patients. With more than 35,000 patients treated and a new FDA clearance in hand, SPR solidified our position as a market leader and continued to expand its reach and influence in the field of pain management.
A future of possibilities
This year will mark our 15th anniversary of the company, and we are approaching the milestone of treating 50,000 patients—a significant achievement in our ongoing mission to improve lives. As we continue to develop new products and explore expanded applications, we remain focused on driving innovation that helps patients reclaim their lives.